MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-05-0048365
Glee Biotech Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹17.11 Cr
▼ 7% YoY
Net profit · FY 2024
₹2.92 Cr
Net margin 17%
EBITDA · FY 2024
₹3.91 Cr
EBITDA margin 22.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹6.53 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
About Glee Biotech Limited
Data last updated:
Glee Biotech Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33100DL2020PLC362536. Its GSTIN is 07AAICG2576Q1ZW (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Rachna Bhatia and Raghav Bhatia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 301 – 302 Block & Pocket B – 4 Sector – 8 Rohini, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.11 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹2.92 Cr (net margin 17%) and EBITDA of ₹3.91 Cr (EBITDA margin 22.8%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years.
The company is associated with 1 brand: Glee Biotech. As per MCA filings, the company has open charges of ₹6.53 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
Glee Biotech Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0048365). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gleebiotech.com.
Company Details of Glee Biotech Limited
CIN U33100DL2020PLC362536
Registration Number 362536
Incorporation Date 03 March 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-05-0048365
Recognitions & Rankings of Glee Biotech
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address301 – 302 Block & Pocket B – 4 Sector – 8 Rohini, New Delhi, Delhi, India – 110085
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Glee Biotech Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Glee Biotech Limited
Glee Biotech operates one associated brand: Glee Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures a range of pharmaceutical products, including generic and branded medications. | gleebiotech.com |
Business Activity of Glee Biotech Limited
The main business activity of Glee Biotech is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Glee Biotech Limited FY 2025 filings available
Glee Biotech Limited reported revenue of ₹17.11 Cr (down 7% YoY) for FY 2024.
Revenue · FY 2024
₹17.11 Cr ▼ 7%
Net profit · FY 2024
₹2.92 Cr margin 17%
EBITDA · FY 2024
₹3.91 Cr margin 22.8%
Compounded Annual Growth Rate (CAGR) of Glee Biotech Limited
Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 37%
Revenue fell 7% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 26%. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Glee Biotech Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.91 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.92 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Glee Biotech Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 17% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Glee Biotech are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Glee Biotech Limited
Glee Biotech has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rachna Bhatia Also directs: Dynamic Infracity Private Limited | Director | 03 Mar 2020 | 6 Years 7 Months | Current |
| Raghav Bhatia Also directs: Phamilymed Private Limited | Director | 03 Mar 2020 | 6 Years 7 Months | Current |
| Kiran Bhatia Also directs: Dynamic Infracity Private Limited | Director | 08 Dec 2020 | 5 Years 10 Months | Current |
Peer Comparison of Glee Biotech Limited
Glee Biotech Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rangodadhi Chemicals Private Limited | ₹17.2 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Ahmedabad, Gujarat, India |
| Wayonext Pharmaceuticals Private Limited | ₹17.13 Cr (FY 2025) | •••• | •••• | 74.0% | •••• | Kalyan, Maharashtra, India |
| Invision Medi Sciences Private Limited | ₹17.12 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Bengaluru, Karnataka, India |
| Nilsan Pharmaceuticals Private Limited | ₹17.12 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | New Delhi, Delhi, India |
| Appulse Formulations Private Limited | ₹17.11 Cr (FY 2024) | •••• | •••• | •••• | Delhi, India | |
| Glee Biotech Limited this company | ₹17.11 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | New Delhi, Delhi, India |
| Vamsi Pharma Private Limited | ₹17.11 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Hyderabad, Telangana, India |
| HLL Biotech Limited | ₹17.08 Cr (FY 2024) | •••• | •••• | -68.0% | •••• | Thiruvananthapuram, Kerala, India |
| Octane Biotech Private Limited | ₹17.08 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Lucknow, Uttar Pradesh, India |
| Sagent Pharmaceuticals Private Limited | ₹17.08 Cr (FY 2025) | •••• | •••• | 434.0% | •••• | Mumbai, Maharashtra, India |
| JMM Formulation Private Limited | ₹17.04 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Kala Amb, Himachal Pradesh, India |
Peers are the five companies nearest above and the five nearest below Glee Biotech by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Glee Biotech Limited
Glee Biotech Limited is audited by K V J & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K V J & CO. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Glee Biotech Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Glee Biotech Limited
Open charges
₹6.53 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Dec 2025 | Others | ₹52 Lakh | Open |
| 25 Sep 2025 | Hdfc Bank Limited | ₹13.63 Lakh | Open |
| 06 Sep 2025 | Hdfc Bank Limited | ₹17.09 Lakh | Open |
| 28 Aug 2025 | Hdfc Bank Limited | ₹6.57 Lakh | Open |
| 02 Aug 2025 | Hdfc Bank Limited | ₹19.49 Lakh | Open |
Total charge records: 22 View all charges
Legal Cases of Glee Biotech Limited
Glee Biotech Limited has 2 court cases on record: 2 filed against it. All cases are disposed. Status as checked between 03 Oct 2026 and 04 Oct 2026.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
| District court, Gautam Buddha Nagar, Uttar Pradesh | Civil suit | Filed against the company by Eternal Care Thermoelectric Solutions | Disposed |
Premium access
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Glee Biotech Limited
Glee Biotech Limited has 2 MSME Form 1 returns on record between 2020 and 2021, listing 5 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Lithous Services Private Limited | •••• | •••• | •••• |
| Hari Om Pack | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Eternal Care Thermoelectric Solutions | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Glee Biotech Limited
Employment history and EPFO contributions of people linked to Glee Biotech.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Glee Biotech Limited
Glee Biotech Limited has 7 board changes on record since 2020: 5 appointments and 2 cessations. The latest: Vikas Khatri ceased to be Director on 15 Sep 2024.
Charges
A charge with Others amounted to Rs. 52.00 Lakh with Charge ID 101215751 was registered on 17 Dec 2025.
AGM
Glee Biotech Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.63 Lakh with Charge ID 101168055 was registered on 25 Sep 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 17.09 Lakh with Charge ID 101160703 was registered on 06 Sep 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 6.57 Lakh with Charge ID 101156532 was registered on 28 Aug 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 19.49 Lakh with Charge ID 101143853 was registered on 02 Aug 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 32.40 Lakh with Charge ID 101144326 was registered on 02 Aug 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 28.32 Lakh with Charge ID 101166562 was registered on 02 Aug 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 28.35 Lakh with Charge ID 101140241 was registered on 22 Jul 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 34.99 Lakh with Charge ID 101140852 was registered on 22 Jul 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 39.29 Lakh with Charge ID 101141102 was registered on 22 Jul 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 31.72 Lakh with Charge ID 101144328 was registered on 22 Jul 2025.
20 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Glee Biotech Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Glee Biotech Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Glee Biotech Limited
Glee Biotech has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICG2576Q1ZW | Delhi | Active | 01 Jul 2020 |
| 06AAICG2576Q1ZY | Haryana | Active | 20 Apr 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Glee Biotech Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glee Biotech Limited
Glee Biotech is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 March 2020 (6+ years old) and is registered under CIN U33100DL2020PLC362536.
Glee Biotech reported revenue of ₹17.11 Cr for FY 2024 (down 7% YoY).
Glee Biotech has 3 current directors:
- Rachna Bhatia - Director
- Raghav Bhatia - Director
- Kiran Bhatia - Director
Glee Biotech reported a net profit of ₹2.92 Cr (net margin 17%) and EBITDA of ₹3.91 Cr (EBITDA margin 22.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Glee Biotech is 26% over three years. In the latest year (FY 2024) revenue fell 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Glee Biotech is 07AAICG2576Q1ZW, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAICG2576Q1ZY (Haryana).
The CIN (Corporate Identification Number) of Glee Biotech is U33100DL2020PLC362536. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glee Biotech has 2 court cases on record: 2 filed against it. Most are in the high courts.
Glee Biotech was incorporated on 03 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Glee Biotech by revenue are Rangodadhi Chemicals Private Limited, Wayonext Pharmaceuticals Private Limited, Invision Medi Sciences Private Limited, Nilsan Pharmaceuticals Private Limited, Appulse Formulations Private Limited and 5 more, all in the Pharma industry (Formulations).
Vikas Khatri ceased to be Director on 15 Sep 2024. Vikas Khatri was appointed as Director on 06 May 2023. Anil Kumar ceased to be Director on 09 Dec 2020. Glee Biotech has 7 board changes on record in total.
Yes, Glee Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-HR-05-0048365).